Cargando…

Association of tear matrix metalloproteinase 9 immunoassay with signs and symptoms of dry eye disease: A cross-sectional study using qualitative, semiquantitative, and quantitative strategies

PURPOSE: This study aimed to analyze the association of tear matrix metalloproteinase 9 (MMP-9) immunoassay with the severity of dry eye (DE) signs and symptoms through qualitative, semiquantitative, and quantitative evaluations of immunoassay band. MATERIALS AND METHODS: This cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, You Hyun, Bang, Seung-Pil, Shim, Kyu-Young, Son, Myung-Jin, Kim, Harim, Jun, Jong Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523049/ https://www.ncbi.nlm.nih.gov/pubmed/34662364 http://dx.doi.org/10.1371/journal.pone.0258203

Ejemplares similares

In vitro validation of the tear matrix metalloproteinase 9 in-situ immunoassay
por: Bang, Seung Pil, et al.
Publicado: (2020)

Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay
por: Jun, Jong Hwa, et al.
Publicado: (2020)

Comparative Evaluation of Matrix Metalloproteinase-9 Immunoassay and Tear Osmolarity Measurement for Diagnosing Severity of Dry Eye Disease
por: Choi, Moonjung, et al.
Publicado: (2023)

Dichotomous versus 5-scale grading system for the interpretation of the point-of-care immunoassay for tear matrix metalloproteinase-9 in dry eye
por: Oh, Ja Young, et al.
Publicado: (2023)

Novel point-of-care biomarkers of the dry anophthalmic socket syndrome: tear film osmolarity and matrix metalloproteinase 9 immunoassay
por: Rokohl, Alexander C., et al.
Publicado: (2022)

Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease
por: Park, Jae Yong, et al.
Publicado: (2018)

PACAP suppresses dry eye signs by stimulating tear secretion
por: Nakamachi, Tomoya, et al.
Publicado: (2016)

High Levels of 17β-Estradiol Are Associated with Increased Matrix Metalloproteinase-2 and Metalloproteinase-9 Activity in Tears of Postmenopausal Women with Dry Eye
por: Shen, Guanglin, et al.
Publicado: (2016)

Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study
por: Greiner, Jack V., et al.
Publicado: (2023)

Assessment of reliability and validity of the 5-scale grading system of the point-of-care immunoassay for tear matrix metalloproteinase-9
por: Kim, Minjeong, et al.
Publicado: (2021)

The Correlation between Matrix Metalloproteinase-9 Point-of-Care Immunoassay, Tear Film Osmolarity, and Ocular Surface Parameters
por: Kang, Min-Ji, et al.
Publicado: (2022)

Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model
por: Bang, Seung Pil, et al.
Publicado: (2019)

Reduced tear thrombospondin‐1/matrix metalloproteinase‐9 ratio can aid in detecting Sjögren's syndrome etiology in patients with dry eye
por: Masli, Sharmila, et al.
Publicado: (2022)

Development and validation of a multiplex electrochemiluminescence immunoassay to evaluate dry eye disease in rat tear fluids
por: Compagnone, Agnese, et al.
Publicado: (2023)

A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018)

Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye
por: Fini, M. Elizabeth, et al.
Publicado: (2020)

Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome
por: Kook, Kyung Yun, et al.
Publicado: (2020)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
por: Pepose, Jay S, et al.
Publicado: (2019)

Tear proteomics in dry eye disease
por: Kannan, Ramaraj, et al.
Publicado: (2023)

Tear matrix metalloproteinase-9 levels may help to follow a ocular surface injury in lagophthalmic eyes
por: Minaříková, Marcela, et al.
Publicado: (2022)

Tear osmolarity and dry eye symptoms in diabetics
por: Fuerst, Nicole, et al.
Publicado: (2014)

Tear Luminex Analysis in Dry Eye Patients
por: Zhao, Hailan, et al.
Publicado: (2018)

Development of a Quantitative Immunoassay for Tear Lacritin Proteoforms
por: Justis, Brooke M., et al.
Publicado: (2020)

Tear Metabolomics in Dry Eye Disease: A Review
por: Yazdani, Mazyar, et al.
Publicado: (2019)

Dry eye: why artificial tears are not always the answer
por: Kim, Minji, et al.
Publicado: (2021)

Functionalized Hyaluronic Acid for “In Situ” Matrix Metalloproteinase Inhibition: A Bioactive Material to Treat the Dry Eye Sydrome
por: Burgalassi, Susi, et al.
Publicado: (2022)

Effects of aerobic exercise on tear secretion and tear film stability in dry eye patients
por: Sun, Chao, et al.
Publicado: (2022)

Relation of accommodative microfluctuation with dry eye symptoms in short tear break-up time dry eye
por: Kaido, Minako, et al.
Publicado: (2017)

Association between dry eye symptoms and signs
por: Kyei, Samuel, et al.
Publicado: (2018)

Practical issues concerning tear protein assays in dry eye
por: D’Souza, Sharon, et al.
Publicado: (2014)

Impact of tear metrics on the reliability of perimetry in patients with dry eye
por: Sagara, Hideto, et al.
Publicado: (2019)

Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease
por: Tashbayev, Bezhod, et al.
Publicado: (2020)

Tear Osmolarity in the Diagnosis of Systemic Dehydration and Dry Eye Disease
por: Bron, Anthony J., et al.
Publicado: (2021)

Tear evaluation by anterior segment OCT in dry eye disease
por: Popovici, Diana Mădălina, et al.
Publicado: (2021)

Changes in Tear Proteome After Acupuncture Treatment in Dry Eye
por: Tong, Louis, et al.
Publicado: (2021)

Association between Dry Eye Parameters Depends on Tear Components
por: Chang, Shu-Wen, et al.
Publicado: (2022)

Personalized Management of Dry Eye Disease: Beyond Artificial Tears
por: Matossian, Cynthia, et al.
Publicado: (2022)

Seeing through tears: Understanding and managing dry eye disease
por: Basu, Sayan
Publicado: (2023)

Tear biomarkers in dry eye disease: Progress in the last decade
por: Kumar, Nimisha R, et al.
Publicado: (2023)

Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females
por: Fineide, Fredrik A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_slnlif2nm49jtk182uapv4fnhh